🔎 Trials Near Me

Akèy › Ateroskleroz › Alabama › Birmingham

Etid klinik pou Ateroskleroz nan Birmingham, AL

4 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3
  • Birmingham Clinical Research, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Birmingham
  • Research Site, Birmingham
  • Research Site, Irondale · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Pelacarsen Roll-over Extension Program

Ap rekriteFaz 3
  • Parkway Medical Center, Birmingham
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 55 · Tout sèks · Mizajou Sep 3, 2025 · NCT06962488

Etid Ateroskleroz nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.